Variable expression of human myeloid specific nuclear antigen MNDA in monocyte lineage cells in atherosclerosis

Journal of Cellular Biochemistry

Volumn 95, Issue 2, 2005, Pages 293-301

  Briggs, Robert C ^a,c   Atkinson, James B ^a   Miranda, Roberto N ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TRUMAN MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Immunohistochemistry; Macrophages; MNDA; Monocytes

Indexed keywords

CD68 ANTIGEN; CELL NUCLEUS ANTIGEN; HUMAN MYELOID NUCLEAR DIFFERENTIATION ANTIGEN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; AORTA; ARTICLE; ATHEROMA; ATHEROSCLEROSIS; CELL DEATH; CELL LINEAGE; CELL SPECIFICITY; CONTROLLED STUDY; CYTOPLASM; DISEASE COURSE; ENDOTHELIUM CELL; FOAM CELL; GENE EXPRESSION REGULATION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MACROPHAGE; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NUCLEAR; AORTA; ARTERIOSCLEROSIS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MONOCYTES;

EID: 26444435397     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20435     Document Type: Article

References (31)

1. Ball RY, Stowers EC, Burton JH, Cary NRB, Skepper JN, Mitchinson MJ. 1995. Evidence that the death of macrophage foam cells contributes to the lipid core of atheroma. Atherosclerosis 114:45-54.
2. Bobryshev YV, Lord RSA. 1998. Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions. Cardiovasc Res 37:799-810.
3. Briggs JA, Burrus GR, Stickney BD, Briggs RC. 1992. Cloning and expression of the human myeloid cell nuclear differentiation antigen: Regulation by interferon α. J Cell Biochem 49:82-92.
4. Briggs RC, Briggs JA, Ozer J, Sealy L, Dworkin LL, Kingsmore SF, Seldin MF, Kaur GP, Athwal RS, Dessypris EN. 1994a. The human myeloid cell nuclear differentiation antigen gene is one of at least two related interferon-inducible genes located on chromosome 1q that are expressed specifically in hematopoietic cells. Blood 83:2153-2162.
5. Briggs RC, Dworkin L, Briggs JA, Dessypris EN, Stein GS, Stein JL, Lian J. 1994b. Interferon alpha selectively affects expression of the human myeloid cell nuclear differentiation antigen in late stage cells in the monocytic but not the granulocytic lineage. J Cell Biochem 54:198-206.
6. Briggs RC, Kao WY, Dworkin LL, Briggs JA, Dessypris EN, Clark J. 1994c. Regulation and specificity of MNDA expression in monocytes, macrophages, and leukemia/B lymphoma cell lines. J Cell Biochem 56:559-567.
7. Brocheriou I, Stengel D, Mattsson-Hulten L, Stankova J, Rola-Pleszczynski M, Koskas F, Wiklund O, Charpentier YL, Ninio E. 2000. Expression of platelet-activating factor receptor in human carotid atherosclerotic plaques. Circulation 102:2569-2575.
8. Burrus GR, Briggs JA, Briggs RC. 1992. Characterization of the human myeloid cell nuclear differentiation antigen: Relationship to interferon-inducible proteins. J Cell Biochem 48:190-202.
9. Datta B, Min W, Burma S, Lengyel P. 1998. Increase in p202 expression during skeletal muscle differentiation: Inhibition of MyoD protein expression and activity by p202. Mol Cell Biol 18:1074-1083.
10. Doggett K, Briggs JA, Linton MF, Fazio S, Head DR, Xie J, Hashimoto Y, Laborda J, Briggs RC. 2002. Retroviral mediated expression of the human myeloid nuclear antigen in a null cell line upregulates Dlk1 expression. J Cell Biochem 86:56-66.
11. Frostgard J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U, Hansson GK. 1999. Cytokine expression in advanced human atherosclerotic plaques: Dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 145:33-43.
12. Galis Z, Sukhova GK, Lark MW, Libby P. 1994. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94:2493-2503.
13. Goldberger A, Brewer G, Hnilica LS, Briggs RC. 1984. Nonhistone protein antigen profiles of five leukemic cell lines reflect the extent of myeloid differentiation. Blood 63:701-710.
14. Goldberger A, Hnilica LS, Casey SB, Briggs RC. 1986. Properties of a nuclear protein marker of human myeloid cell differentiation. J Biol Chem 261:4726-4731.
15. Hakkinen T, Karkola K, Yla-Herttuala S. 2000. Macrophages, smooth muscle cells, endothelial cells, and T-cells express CD40 and CD40L in fatty streaks and more advanced human atherosclerotic lesions. Virchows Arch 437:396-405.
16. Halpert I, Sires UI, Roby JD, Potter-Perigo S, Wight TN, Shapiro SD, Welgus HG, Wickline SA, Parks WC. 1996. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc Natl Acad Sci USA 93: 9748-9753.
17. Hudson CR, Bellew T, Briggs JA, Casey SB, Briggs RC. 1988. Production and use of rat monoclonal antibodies to the human myeloid cell nuclear differentiation antigen. Hybridoma 7:541-553.
18. Johnstone RW, Kerry JA, Trapani JA. 1998. The human interferon-inducible protein, IFI16, is a repressor of transcription. J Biol Chem 273:17172-17177.
19. Johnstone RW, Wei W, Greenway A, Trapani JA. 2000. Functional interaction between p53 and the interferon-inducible nucleoprotein IFI16. Oncogene 19:6033-6042.
20. Laborda J. 2000. The role of the epidermal growth factor-like protein dlk in cell differentiation. Histol Histopathol 15:119-129.
21. Landolfo S, Gariglio M, Gribaudo G, Lembo D. 1998. The Ifi 200 genes: An emerging family of IFN-inducible genes. Biochimie 80:721-728.
22. Luna LG. 1968. Manual of histologic staining methods of the Armed Forces Institute of Pathology. 3rd edition. New York: McGraw-Hill Book Company.
23. Miranda RN, Briggs RC, Shults K, Kinney MC, Jensen RA, Cousar JB. 1999. Immunocytochemical analysis of MNDA in tissue sections and sorted normal bone marrow cells documents expression only in maturing normal and neoplastic myelomonocytic cells and a subset of normal and neoplastic B lymphocytes. Hum Pathol 30:1040-1049.
24. Ohno N, Izawa A, Hattori M, Kageyama R, Sudo T. 2002. dlk inhibits stem cell factor-induced colony formation of murine hematopoietic progenitors: Hes-1-independent effect. Stem Cells 19:71-79.
25. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. 1993. Natural history of aortic and coronary atherosclerotic lesions in youth. Findings from the PDAY study. Arterioscler Thromb Vasc Biol 13: 1291-1298.
26. Shiffman D, Mikita T, Tai JTN, Wade DP, Porter JG, Seihamer JJ, Somogy R, Liang S, Lawn RM. 2000. Large scale gene expression analysis of cholesterol-loaded macrophages. J Biol Chem 275:37324-37332.
27. Staub E, Dahl E, Rosenthal A. 2001. The DAPIN family: A novel domain links apoptotic and interferon response proteins. Trends Biochem Sci 26:83-85.
28. Sugiyama S, Okada Y, Sukhova GK, Virmani R, Heinecke JW, Libby P. 2001. Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol 158:879-891.
29. Wang H, Liu CJ, Lu Y, Chatterjee G, Ma XY, Eisenman RN, Lengyel P. 2000. The interferon- and differentiation-inducible p202a protein inhibits the transcriptional activity of c-Myc by blocking its association with Max. J Biol Chem 275:27377-27385.
30. Xie J, Briggs JA, Briggs RC. 1997. MNDA dimerizes through a complex motif involving an N-terminal basic region. FEBS Lett 408:151-155.
31. Xie J, Briggs JA, Briggs RC. 1998. Human myeloid nuclear antigen MNDA interacts with YY1 and stimulates DNA binding. J Cell Biochem 70:489-506.